2026

Regulatory Approvals

After a Decade Without New Options, FDA Clears Rybrevant Faspro for Head and Neck Cancer

Nov 9, 2026

After a Decade Without New Options, FDA Clears Rybrevant Faspro for Head and Neck Cancer GeneOnline

Regulatory Approvals

Genmab shares rise 4% on J&J cancer drug FDA approval

Nov 9, 2026

Genmab shares rise 4% on J&J cancer drug FDA approval Investing.com

Credit Ratings

Chailease stock faces negative outlook after Fitch rating action – ad-hoc

Nov 9, 2026

Chailease stock faces negative outlook after Fitch rating action ad-hoc-news.de

Credit Ratings

Fitch Affirms IHS Holding at ‘B+’ With Positive Outlook

Nov 9, 2026

Fitch Affirms IHS Holding at ‘B+’ With Positive Outlook MarketForces Africa

Credit Ratings

Poland’s Domanski blames presidential vetoes as S&P cuts outlook to negative

Nov 9, 2026

Poland’s Domanski blames presidential vetoes as S&P cuts outlook to negative Investing.com

Mergers & Acquisitions

RadNet Acquires Radiology Staffer in $350 Million Deal

Mergers & Acquisitions

Tesla–SpaceX Union Would Test Texas Business Code Merger Process

Mergers & Acquisitions

Food Lion to acquire five Winn-Dixie stores in Southern Georgia, exceeding 2026 growth plan

Mergers & Acquisitions

Crédit Agricole Proposes Merger of Italian Business With Banco BPM